CING · Cingulate Inc.
$5.05
+0.11 (+2.23%)
At close · Aug 6
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company can give no assurance that its plans will be effectively implemented in such a way that they will sufficiently alleviate or mitigate the conditions and events noted above, which results in substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$67.04M
Shares
13.28M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.05
Open$4.95
Day$4.92–5.10
52W$3.16–11.89
Avg vol 30d243K
Short int1.7M · 12.6% float · 4.8d
Short vol58%
Last earningsMay 29, 2025
DataDec 2021–Aug 2026
Filing10-Q · May 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Neutral
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−1%
below
Price vs 50-day avg
+6%
above
RSI (14)
58
neutral
MACD trend
Positive
52-week position
22%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+2%
trailing
6-month return
−19%
trailing
YTD return
+16%
this year
Relative strength
−32%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
9 of 27 funds reported for Jun 30 · net +206.4K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.64% of float · ▲ +22.0% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
27 holders — near 3-yr high, broad support
Squeeze score
79
high risk · 0–100
Fundamentals
EPS growth
+59%
Y/Y
Free cash flow
$-17.4M
Balance sheet
$11.0M
net cash
Quant / Vol
risk profile
Volatility
91%
annualized · 1-yr
Max drawdown
−69%
past year
ATR
6.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−1%
Neutral
Price vs 50-day avg
+6%
Bullish
RSI (14)
58
Neutral
MACD trend
Positive
Bullish
52-week position
22%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
9 of 27 funds reported for Jun 30 · net +206.4K sh shares · +3 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.64% of float · ▲ +22.0% MoM · 4.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
27 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $3
Now $5 · 22%
52-wk high $12
vs 200-day avg -1%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CING
this stock
Cingulate Inc.
|
$67.04M | +16.4% | — | — | 12.6% |
|
ONC
BeOne Medicines Ltd.
|
$487.49B | +8.6% | +22179.2% | 749.6 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$122.89B | +6.8% | +46.2% | 28.2 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$79.13B | +0.3% | +20.8% | 19.0 | 3.4% |
|
ARGX
Argenx SE
|
$54.76B | +4.1% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CING | +6.1% | +2.0% | -18.8% | +5.4% | +16.4% |
| SPY | +3.6% | +2.2% | +12.8% | +2.9% | +12.7% |
| vs SPY | +2.5% | -0.2% | -31.6% | +2.6% | +3.7% |